• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清基质金属蛋白酶-9和金属蛋白酶组织抑制因子-1水平与左心室指标及心血管危险因素的关系:一项基于人群的研究。

Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.

作者信息

Hansson Jonas, Lind Lars, Hulthe Johannes, Sundström Johan

机构信息

Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

出版信息

Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):297-303. doi: 10.1097/HJR.0b013e3283213108.

DOI:10.1097/HJR.0b013e3283213108
PMID:19387352
Abstract

BACKGROUND

Extracellular matrix remodeling is a hallmark of pathological left ventricular (LV) hypertrophy and heart failure. This process is tightly controlled by the degrading matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). We hypothesized that circulating MMP-9 and TIMP-1 levels are altered already in persons with the signs of LV remodeling that forego clinical heart failure.

DESIGN

Cross-sectional study in the Prospective Investigation of the Vasculature in Uppsala Seniors, a community-based cohort of 891 70-year-old men and women free from valvular disease, heart failure, and myocardial infarction.

METHODS

We examined relations of serum MMP-9 and TIMP-1 to echocardiographic LV geometry and function. All models were adjusted for sex, height, intra-arterial systolic and diastolic blood pressures, antihypertensive medication use, and serum freezer time.

RESULTS

Serum TIMP-1 was positively related to LV mass and wall thickness (r=0.15, P<0.0001 and r=0.16, P<0.0001, respectively), with a 32 g higher LV mass and 2.2 mm thicker walls in the fourth compared with the first quartile of serum TIMP-1. Serum TIMP-1 was also inversely related to LV ejection fraction (r=-0.10, P=0.009), but not to LV dimension or diastolic function indices. Serum MMP-9 was only weakly related to LV wall thickness and isovolumic relaxation time (r=0.08, P=0.04 and r=-0.08, P=0.04).

CONCLUSION

In this large population-based sample, serum TIMP-1 levels were related to LV mass, wall thickness, and inversely to systolic function. This may imply that extracellular matrix remodeling is involved already in the earliest stages of the process leading to heart failure.

摘要

背景

细胞外基质重塑是病理性左心室(LV)肥厚和心力衰竭的一个标志。这一过程受降解性基质金属蛋白酶(MMPs)及其组织抑制剂(TIMPs)的严格控制。我们推测,在出现左心室重塑迹象但尚未发生临床心力衰竭的人群中,循环中的MMP - 9和TIMP - 1水平已经发生改变。

设计

在乌普萨拉老年人血管前瞻性研究中进行的横断面研究,该研究是一个基于社区的队列,包含891名70岁且无瓣膜疾病、心力衰竭和心肌梗死的男性和女性。

方法

我们研究了血清MMP - 9和TIMP - 1与超声心动图左心室几何形状和功能之间的关系。所有模型均对性别、身高、动脉内收缩压和舒张压、抗高血压药物使用情况以及血清冷冻时间进行了校正。

结果

血清TIMP - 1与左心室质量和壁厚呈正相关(分别为r = 0.15,P < 0.0001和r = 0.16,P < 0.0001),血清TIMP - 1第四四分位数组与第一四分位数组相比,左心室质量高32 g,壁厚厚2.2 mm。血清TIMP - 1也与左心室射血分数呈负相关(r = -0.10,P = 0.009),但与左心室尺寸或舒张功能指标无关。血清MMP - 9仅与左心室壁厚和等容舒张时间呈弱相关(r = 0.08,P = 0.04和r = -0.08,P = 0.04)。

结论

在这个基于大量人群的样本中,血清TIMP - 1水平与左心室质量、壁厚相关,与收缩功能呈负相关。这可能意味着细胞外基质重塑在导致心力衰竭的过程的最早阶段就已涉及。

相似文献

1
Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study.血清基质金属蛋白酶-9和金属蛋白酶组织抑制因子-1水平与左心室指标及心血管危险因素的关系:一项基于人群的研究。
Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):297-303. doi: 10.1097/HJR.0b013e3283213108.
2
Tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9 levels in patients with hypertension Relationship to tissue Doppler indices of diastolic relaxation.高血压患者中基质金属蛋白酶-1组织抑制剂和基质金属蛋白酶-9水平与舒张期松弛组织多普勒指标的关系
Am J Hypertens. 2004 Sep;17(9):770-4. doi: 10.1016/j.amjhyper.2004.06.023.
3
Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.基质金属蛋白酶/金属蛋白酶组织抑制剂:基质成分蛋白水解决定因素的变化与高血压性心脏病的结构、功能及临床表现之间的关系
Circulation. 2006 May 2;113(17):2089-96. doi: 10.1161/CIRCULATIONAHA.105.573865. Epub 2006 Apr 24.
4
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.血浆基质金属蛋白酶-9与临床心血管危险因素及超声心动图左心室测量指标的关系:弗明汉心脏研究
Circulation. 2004 Jun 15;109(23):2850-6. doi: 10.1161/01.CIR.0000129318.79570.84. Epub 2004 Jun 1.
5
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study.血浆总基质金属蛋白酶组织抑制因子-1水平与心血管危险因素及超声心动图测量指标的关系:弗明汉心脏研究
Eur Heart J. 2004 Sep;25(17):1509-16. doi: 10.1016/j.ehj.2004.05.029.
6
Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.绝经前肥胖女性体内的基质金属蛋白酶2和9及其组织抑制剂1和2:与心脏功能的关系
Int J Obes (Lond). 2008 May;32(5):763-71. doi: 10.1038/sj.ijo.0803794. Epub 2008 Jan 15.
7
Plasma matrix metalloproteinase-9 level is correlated with left ventricular volumes and ejection fraction in patients with heart failure.血浆基质金属蛋白酶-9水平与心力衰竭患者的左心室容积和射血分数相关。
J Card Fail. 2006 Sep;12(7):514-9. doi: 10.1016/j.cardfail.2006.05.012.
8
Plasma metalloproteinase levels and left ventricular remodeling in hypertrophic cardiomyopathy in patients with an identical mutation.同一致病突变的肥厚型心肌病患者的血浆金属蛋白酶水平与左心室重构。
J Cardiol. 2011 Nov;58(3):261-5. doi: 10.1016/j.jjcc.2011.07.011. Epub 2011 Sep 3.
9
[Matrix metalloproteinases: significance in remodeling of the myocardium in valvular heart disease].[基质金属蛋白酶:在瓣膜性心脏病心肌重塑中的意义]
Kardiologiia. 2007;47(12):49-52.
10
Excessive activation of matrix metalloproteinases coincides with left ventricular remodeling during transition from hypertrophy to heart failure in hypertensive rats.在高血压大鼠从肥大向心力衰竭转变过程中,基质金属蛋白酶的过度激活与左心室重塑同时发生。
J Am Coll Cardiol. 2002 Apr 17;39(8):1384-91. doi: 10.1016/s0735-1097(02)01756-4.

引用本文的文献

1
Not just a witness: Highlighting the utility of witness social defeat stress for the examination of neuroimmune-cardiovascular interactions across diverse populations.不仅仅是一个见证者:凸显见证者社会挫败应激在研究不同人群神经免疫与心血管相互作用方面的效用。
Neurobiol Stress. 2025 Aug 12;38:100751. doi: 10.1016/j.ynstr.2025.100751. eCollection 2025 Sep.
2
Assessment of Left Ventricular Strain Echocardiography in Individuals with Hashimoto's Thyroiditis and Its Association with Serum TIMP-1 Concentration.桥本甲状腺炎患者左心室应变超声心动图评估及其与血清基质金属蛋白酶组织抑制因子-1浓度的关系
J Clin Med. 2025 Mar 3;14(5):1705. doi: 10.3390/jcm14051705.
3
The Role of Dietary Anthocyanins for Managing Diabetes Mellitus-Associated Complications.
膳食花青素在管理糖尿病相关并发症中的作用。
Curr Diabetes Rev. 2025;21(9):e15733998322754. doi: 10.2174/0115733998322754240802063730.
4
Matrix Metalloproteinases and Heart Transplantation-A Pathophysiological and Clinical View.基质金属蛋白酶与心脏移植:病理生理学与临床观察
Medicina (Kaunas). 2023 Jul 13;59(7):1295. doi: 10.3390/medicina59071295.
5
Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus.2 型糖尿病患者纤维化标志物与心力衰竭发生率的关系。
J Diabetes Res. 2021 Nov 5;2021:9589185. doi: 10.1155/2021/9589185. eCollection 2021.
6
A High-Cholesterol Diet Increases Toll-like Receptors and Other Harmful Factors in the Rabbit Myocardium: The Beneficial Effect of Statins.高胆固醇饮食增加兔心肌中的 Toll 样受体和其他有害因子:他汀类药物的有益作用。
Curr Issues Mol Biol. 2021 Jul 26;43(2):818-830. doi: 10.3390/cimb43020059.
7
The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.基质金属蛋白酶及其抑制剂在人类疾病中的作用。
Int J Mol Sci. 2020 Dec 20;21(24):9739. doi: 10.3390/ijms21249739.
8
Serum tissue inhibitor of metalloproteinase-1 and risk of cognitive impairment after acute ischaemic stroke.血清金属蛋白酶组织抑制剂-1 与急性缺血性脑卒中后认知障碍的风险。
J Cell Mol Med. 2020 Jul;24(13):7470-7478. doi: 10.1111/jcmm.15369. Epub 2020 May 20.
9
Plasma matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs and aging and lifelong exercise adaptations in ventricular and arterial stiffness.血浆基质金属蛋白酶(MMPs)及其组织抑制剂与衰老和终生运动对心室和动脉僵硬度的适应性改变。
Exp Gerontol. 2019 Aug;123:36-44. doi: 10.1016/j.exger.2019.05.004. Epub 2019 May 13.
10
Effects of neprilysin-renin inhibition in comparison with neprilysin-angiotensin inhibition on the neurohumoral changes in rats with heart failure.血管紧张素转化酶抑制剂与脑啡肽酶抑制剂对心力衰竭大鼠神经内分泌变化的影响比较。
BMC Pharmacol Toxicol. 2019 May 3;20(1):23. doi: 10.1186/s40360-019-0304-z.